Drilldown: Medicines
Appearance
Medicines > routes:
IV
& duration
:
4-8 hours typical; longer at high doses; residual cognitive and perceptual effects up to 48 hours
or
N/A (replacement) 
& duration
:
4-8 hours typical; longer at high doses; residual cognitive and perceptual effects up to 48 hours
or
N/A (replacement) 
Use the filters below to narrow your results.
[[:Category:Anesthetics|Anesthetic (historical)]] (1) ·
[[:Category:Arylcyclohexylamines|Arylcyclohexylamine]] (1) ·
[[:Category:B-vitamins|B-vitamin]] (2) ·
[[:Category:Dissociatives|Dissociative]] (1) ·
[[:Category:Hematinics|Hematinic]] (2) ·
[[:Category:NMDA_receptor_antagonists|NMDA receptor antagonist]] (1) ·
[[:Category:Sigma-1_receptor_agonists|Sigma-1 receptor agonist]] (1) ·
[[:Category:Vitamins|Vitamin]] (2)
'"`UNIQ--vote-00000063-QINU`"', '"`UNIQ--vote-00000064-QINU`"' (1) ·
'"`UNIQ--vote-000005B3-QINU`"', '"`UNIQ--vote-000005B4-QINU`"', '"`UNIQ--vote-000005B5-QINU`"', '"`UNIQ--vote-000005B6-QINU`"' (1) ·
'"`UNIQ--vote-00000607-QINU`"', '"`UNIQ--vote-00000608-QINU`"', '"`UNIQ--vote-00000609-QINU`"', '"`UNIQ--vote-0000060A-QINU`"' (1)
0.4 mg PO daily (general prevention); 0.8-1 mg/d in pregnancy; 4 mg/d for women with prior NTD-affected pregnancy; 1 mg/d during methotrexate therapy (1) ·
No current medical indication. Historical anesthetic dose 0.25 mg/kg IV (Sernyl). (1) ·
Replacement: 1000 mcg IM daily for 1 week, then weekly for 4 weeks, then monthly; or 1000-2000 mcg PO daily (effective even in pernicious anemia via passive diffusion); intranasal 500 mcg weekly (1)
0.4, 0.8, 1 mg OTC; 1 mg Rx; 5 mg/mL injection (1) ·
100, 250, 500, 1000, 5000 mcg tablets (OTC and Rx); 1000 mcg/mL injection; intranasal spray; sublingual (1) ·
Historical: Sernyl 25 mg tablets, 10 mg/mL injection (human); Sernylan 100 mg/mL injection (veterinary). Illicit: white crystalline powder, oily liquid, "dipped" cigarettes ("wet"), tablets. (1)
None (1) ·
Routinely supplemented in pregnancy and preconception to prevent neural tube defects.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Routinely supplemented in vegan pregnancies and pernicious anemia.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
OTC (low-dose) and [[USLegal:Prescription only|Rx-only]] (1 mg, injectable) in US (1) ·
OTC (low/mid-dose oral) and [[USLegal:Prescription only|Rx-only]] (injection, intranasal) in US (1) ·
[[USLegal:DEA Schedule II|Schedule II]] controlled substance in US (rescheduled from Schedule III in 1978). No accepted medical use. UN Convention on Psychotropic Substances Schedule II internationally.'"`UNIQ--ref-00000067-QINU`"' (1)
Showing below up to 3 results in range #1 to #3.

